(5-methyltetrahydrofolate) and serum folate was not observed." This finding contrasts previous studies of children where a positive correlation was found. 2, 3 Further, the previous studies estimated the ratio of CSF to serum folate to be about 3, 2, 3 which is in contrast to the much lower ratio (approximately 1) found by the authors. 1 Shoffner et al. defined low CSF folate as ,40 nmol/L and based all analyses around this cutpoint. The difficulty with this approach is that CSF folate is a continuous measure and the cutpoint currently has little supporting research evidence. For instance, if the value of 72 nmol/L (the lower value for children aged 5-10 given by Aylett et al. 4 ) were applied to figure 1,   1 it could be concluded that most children had low CSF folate at both visit 1 and visit 2.
Considerable research is still needed on this topic. What is most important: the absolute value of CSF folate, the ratio of CSF to serum folate, or both? How do these relate to neurologic symptoms? Ultimately, who will benefit from folinate (a relatively safe and inexpensive therapy)?
